AFFINERGY, LLC — Department of Health and Human Services SBIR Phase II: 300

AFFINERGY, LLC — SBIR Phase II award from Department of Health and Human Services.

Amount
$2,108,337
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase II
Topic
300
Solicitation
PA13-234
NAICS
Place of performance
NC
Period
2014-09-15 → 2018-05-31

Description

DESCRIPTION provided by applicant Burn injuries and chronic wounds present a significant burden to patients and the US healthcare system Each year in the US there are burns that require medical treatment and burn patients that require hospitalization The mortality rate associated with severe burns can be as high as with of patient deaths arising from infection In addition to the risk of infection delays in burn wound closure prolong pain increase the chance of hypertrophic scarring or graft rejection and multiply the number of operative procedures Meanwhile venous ulcers occur in to US patients and of these patients will not respond to current treatments In addition to of patients with diabetes will suffer a chronic foot wound and up to of these wounds will eventually require amputation Stem cells can address the unmet needs in burn and wound therapy by accelerating the rate of vascularization and collagen deposition and by attenuating the inflammatory response Adipose derived mesenchymal stem cells ASCs and bone marrow derived mesenchymal stem cells BMSCs secrete a broad range of proteins that are crucial for neovascularization extracellular matrix ECM remodeling and the attenuation of an inflammatory response Multiple pre clinical and clinical reports suggest that ASCs and BMSCs improve healing of burn injuries and acute and chronic wounds However the use of expanded and cultured cells increases the time and cost of medical procedures and can delay treatment Therefore a product that can capture ASCs or BMSCs from autologous tissue at the point of care would have significant advantages over the use of cultured cells In this project we propose to develop a peptide coating for skin substitutes to capture and retain ASCs at the point of care When used to treat chronic wounds and severe burns the peptide coated skin substitute will accelerate vascularization and healing and provide substantially better outcomes for patients PUBLIC HEALTH RELEVANCE Adult stem cells provide numerous advantages to speed up the healing process of burn injuries and wounds In this application we propose to modify skin substitutes with a coating that will allow surgeons to capture adult stem cells onto the skin substitute during the operation Capturing adult stem cells at the point of care will reduce the costs associated with processing and expanding cells and delivery of autologous therapeutic cells will provide better and faster healing